P16 accumulation, which correlates with other makers of senescence, has been shown to increase as early as 4 months of age in hippocampus of the MAPT P301S PS19 mouse model of tau-dependent neurodegenerative disease (Bussian et al., 2018). Here, MAPT is linked to neurodegenerative disease.